Human TruStain FcX™ (Fc Receptor Blocking Solution)

Pricing & Availability
Regulatory Status
RUO
Other Names
Fc Blocker, FcγR blocker, Fc inhibitor
Ave. Rating
Submit a Review
Product Citations
publications
A_Human_TruStain_FcX_031110
Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant mouse IgG2a PE mAb (above). Dotted histogram represents unstained cells.
  • A_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant mouse IgG2a PE mAb (above). Dotted histogram represents unstained cells.
  • A_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant rat IgG2b PE mAb (above). Dotted histogram represents unstained cells.
  • C_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (filled histograms) or non-treated (open histograms) THP-1 cells stained with anti-human HLA-DR PE (red) or an isotype control (IgG2a PE, blue) mAbs. Note: non-treated cells show false-negative HLA-DR staining due to high binding of mouse IgG2a isotype.
Cat # Size Price Quantity Check Availability Save
422301 50 tests 81€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
422302 200 tests 184€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Human Fc receptors (FcRs) are expressed on a variety of cells, such as monocytes, granulocytes, B cells and dendritic cells. The cells with FcR expression sometimes give false positive or false negative results of immunofluorescent staining due to the FcRs-mediated Ig Fc binding. Human TruStain FcX™ is specially formulated for blocking the FcR-involved unwanted staining without interfering with antibody-mediated specific staining of human cells. Human TruStain FcX™ is compatible with flow cytometric staining with anti-human CD16 (clone 3G8), CD32 (clone FUN-2), and CD64 (clone 10.1) antibodies.

Product Details
Technical data sheet

Product Details

Storage & Handling
Store between 2°C and 8°C.
Application

FC - Quality tested
ICFC, ICC - Reported in the literature, not verified in house

Recommended Usage

It is recommended to add 5 µl of Human TruStain FcX™ per million cells in 100 µl staining volume, mix and incubate at room temperature for 5-10 minutes prior to staining with antibody of interest. It is not necessary to wash cells between these blocking and immunostaining steps.

Application Notes

This buffer contains specialized human IgG in PBS containing 0.09% sodium azide. It is not recommended to be used for staining human IgG. Handle as biohazard agent.

Application References

(PubMed link indicates BioLegend citation)
  1. de la Cruz J, et al. 2011. J. Immunol. 186:2282. PubMed
  2. Luo L, et al. 2011. Exp Mol Pathol. 91:596. PubMed
  3. Szerlip NJ, et al. 2012. PNAS. 109:3041. PubMed
  4. Bromley SK, et al. 2013. J. Immunol. 190:970. PubMed
  5. Trujilo G, et al. 2013. J. Immunol. 191:848. PubMed
  6. Edin S, et al. 2013. PLoS One. 18:74982. PubMed
  7. Euzebio Alves VT, et al. 2013. Infect Immun. 81:4399. PubMed
  8. Borg ZD, et al. 2014. J. Immunol. 192:189. PubMed
  9. Klingenberg R, et al. 2014. Eur Heart J. PubMed
  10. Lines JL, et al. 2014. Cancer Res. 74:1924. PubMed
  11. Decker D, et al. 2014. Lupus. 23:802. PubMed
  12. Jitschin R, et al. 2014. Blood. 123:2663. PubMed
  13. Anderson ME Jr, et al. 2014. Otolaryngol Head Neck Surg. 150:880. PubMed
  14. Giurisato E, et al. 2014. Mol Biol Cell. 25:1769. PubMed
  15. Shi J, et al. 2014. Blood. 123:4015. PubMed
  16. Kusner LL, et al. 2014. PLoS One. 9:102231. PubMed
  17. Fujisawa D, et al. 2014. J Allergy Clin Immunol. 134:622. PubMed
  18. Bhardwaj N, et al. 2014. J Virol. 88:11108. PubMed
  19. Lieber S, et al. 2014. Mol Pharmacol. 87:162. PubMed
  20. Olagnier D, et al. 2014. PLoS Pathog. 10:1004566. PubMed
  21. Punyadee N, et al. 2015. J Virol. 89:1587. PubMed
  22. Vuong TT, et al. 2015. J Histochem Cytochem. 63:280. PubMed
  23. Klingenberg R, et al. 2015. Eur Heart J. 36:1041. PubMed
  24. Wilkinson-Ryan I, et al. 2015. PLoS One.10:125851. PubMed
Product Citations
  1. Argüello RJ, et al. 2020. Cell Metab. 32:1063. PubMed
  2. Aguilar EG, et al. 2021. Blood Adv. 5:4219. PubMed
  3. Lambert E, et al. 2022. Acta Neuropathol Commun. 10:4. PubMed
  4. Tocheva AS, et al. 2020. Curr Protoc Immunol. 130:e103. PubMed
  5. Ptacin JL, et al. 2021. Nat Commun. 12:4785. PubMed
  6. Lau D, et al. 2022. Nat Commun. 13:4053. PubMed
  7. Sipe CJ, et al. 2022. Int J Mol Sci. 23:. PubMed
  8. Alber S, et al. 2022. Front Immunol. 13:838636. PubMed
  9. Palacios-Arreola M, et al. 2017. Sci Rep. 10.1038/s41598-017-10135-1. PubMed
  10. Chen X, et al. 2019. Exp Ther Med. 1.265972222. PubMed
  11. Fisher RC, et al. 2019. Neoplasia. 1.061805556. PubMed
  12. Winkler CW, et al. 2019. J Neuroinflammation. 0.825694444. PubMed
  13. O'Huallachain M, et al. 2020. Commun Biol. 3:213. PubMed
  14. Klingenberg R, et al. 2014. Eur Heart J. . PubMed
  15. Fujisawa D, et al. 2014. J Allergy Clin Immunol. 134:622. PubMed
  16. Simon A, et al. 2015. Blood. 126: 378 - 385. PubMed
  17. Mitton B, et al. 2016. Leukemia. 10.1038/leu.2016.139. PubMed
  18. Wanke F, et al. 2017. Cell Rep. 18(5):1270-1284. PubMed
  19. Ecker JW, et al. 2020. Vaccines (Basel). 8:00. PubMed
  20. Liu C, et al. 2021. Cell. 184(7):1836-1857.e22. PubMed
  21. Tsai AG, et al. 2020. Nat Med. 408:26. PubMed
  22. Mehta P, et al. 2021. J Immunol. 207:1763. PubMed
  23. Lam B, et al. 2021. Cell Rep. 37:109838. PubMed
  24. de Cevins C, et al. 2021. Med (N Y). 2:1072. PubMed
  25. Gouin KH, et al. 2021. Nat Commun. 12:4906. PubMed
  26. Stanzione M, et al. 2022. Sci Adv. 8:eabn1229. PubMed
  27. Yoshida M, et al. 2022. Nature. 602:321. PubMed
  28. Egnuni T, et al. 2021. Pharmaceutics. 13:. PubMed
  29. Delvecchio FR, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1543. PubMed
  30. Jundi B, et al. 2021. JCI Insight. 6:e148866. PubMed
  31. Starlard–Davenport A, et al. 2019. Br J Haematol. 186:91. PubMed
  32. Wartewig T, et al. 2017. Nature. . 10.1038/nature24649. PubMed
  33. Friebel E, et al. 2020. Cell. 181(7):1626-1642.e20. PubMed
  34. Ferrari de Andrade L, et al. 2020. Cancer Immunol Res. 0.867361111. PubMed
  35. Biasci D, et al. 2020. Proc Natl Acad Sci U S A. 117:28960. PubMed
  36. Glass DR, et al. 2020. Immunity. 53:217. PubMed
  37. Jackson S, et al. 2016. J Exp Med. 213: 733 - 750. PubMed
  38. Shin J, et al. 2016. Sci Rep. 6:23426. PubMed
  39. Vuong T, et al. 2015. J Histochem Cytochem. 63:280. PubMed
  40. Kusner L, et al. 2014. PLoS One. 9:102231. PubMed
  41. Lee E, et al. 2021. Sci Rep. 11:14841. PubMed
  42. Doerflinger M, et al. 2021. Clin Transl Immunology. 10:e1235. PubMed
  43. Chen L, et al. 2021. Int J Mol Sci. 22:. PubMed
  44. Chen GM, et al. 2021. Cancer Discov. 11:2186. PubMed
  45. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  46. Rip J, et al. 2021. Bio Protoc. 11:e3902. PubMed
  47. Cluff E, et al. 2022. Cancer Immunol Immunother. . PubMed
  48. Mylka V, et al. 2022. Genome Biol. 23:55. PubMed
  49. Jairaman A, et al. 2022. Elife. 11:. PubMed
  50. Takano T, et al. 2022. Cell Rep Med. 3:100631. PubMed
  51. Vinjamur DS, et al. 2021. Nat Genet. 53:719. PubMed
  52. Judge SJ, et al. 2022. Front Immunol. 13:893177. PubMed
  53. Lo MW, et al. 2022. Clin Transl Immunology. 11:e1413. PubMed
  54. Masuda K, et al. 2022. JCI Insight. 7:. PubMed
  55. Patel T, et al. 2022. Aging Cell. 21:e13606. PubMed
  56. Raju R, et al. 2017. Stem Cells Dev. 26:274. PubMed
  57. Karagiannis TT, et al. 2020. Nat Commun. 2.271527778. PubMed
  58. Trujillo G, et al. 2013. J Immunol. 191:848. PubMed
  59. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  60. Mogilenko DA, et al. 2020. Immunity. 54(1):99-115.e12. PubMed
  61. Nielsen CM, et al. 2021. Cell Reports Medicine. 2(3):100207. PubMed
  62. Goveia J, et al. 2020. Cancer Cell. 21:37. PubMed
  63. Mayer RL, et al. 2022. Nat Commun. 13:6075. PubMed
  64. Wang M, et al. 2022. Immun Inflamm Dis. 10:e626. PubMed
  65. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  66. Pérez-Pérez S, et al. 2022. Biomedicines. 10:. PubMed
  67. Figueroa-Romero C, et al. 2022. Front Immunol. 13:773288. PubMed
  68. Chen X, et al. 2022. Front Immunol. 12:807134. PubMed
  69. Emmons TR, et al. 2021. Cancer Immunol Res. 9:790. PubMed
  70. Snyder ME, et al. 2021. Am J Respir Crit Care Med. 203:1230. PubMed
  71. Feng WW, et al. 2019. Cell Rep. 29:3405. PubMed
  72. Li Z, et al. 2018. Exp Ther Med. 3.410416667. PubMed
  73. Klichinsky M, et al. 2020. Nat Biotechnol. 38:947. PubMed
  74. Gupta S, et al. 2020. Proc Natl Acad Sci U S A. 117:16481. PubMed
  75. AC Belkina, JE Snyder-Cappione 2017. Cytometry A. 91:175-179. PubMed
  76. Lindgren I, et al. 2016. Hum Reprod. 31: 672 - 683. PubMed
  77. Beljanski V, et al. 2015. J Virol. 89: 10612 - 10624. PubMed
  78. Pontarini E, et al. 2015. Rheumatology. 54: 1429-1434. PubMed
  79. Harris MJ, et al. 2021. Mol Syst Biol. 17:e10091. PubMed
  80. Liu C, et al. 2021. Cell Res. 31:1106. PubMed
  81. Pickering H, et al. 2021. JCI Insight. 6:. PubMed
  82. Nugent JL, et al. 2021. iScience. 24:103421. PubMed
  83. Chen Z, et al. 2022. J Nanobiotechnology. 20:30. PubMed
  84. Ogbe A, et al. 2022. JCI Insight. . PubMed
  85. Sun V, et al. 2021. Front Immunol. 12:716661. PubMed
  86. Andrews JM, et al. 2021. EBioMedicine. 71:103559. PubMed
  87. Apostolidis SA, et al. 2022. Front Immunol. 13:834988. PubMed
  88. Woodruff MC, et al. 2022. Nature. :. PubMed
  89. Wang L, et al. 2022. Theranostics. 12:7216. PubMed
  90. Wright AKA, et al. 2017. J Allergy Clin Immunol. 140:1430. PubMed
  91. Al–Marsoummi S, et al. 2019. Cell Physiol Biochem. 53:999. PubMed
  92. Weisberg SP, et al. 2020. Cell Reports. 29(12):3916-3932.e5.. PubMed
  93. Seamon K, et al. 2020. Front Immunol. 11:396. PubMed
  94. Jama B, Morris G 2014. J Vis Exp. 93: 52257. PubMed
  95. Patera A, et al. 2016. J Leukoc Biol. 100(6):1239-1254. PubMed
  96. Shi Z, et al. 2021. Ann Clin Transl Neurol. 8:43. PubMed
  97. Woodruff MC, et al. 2020. Nat Immunol. 1.920833333. PubMed
  98. Wang E, et al. 2021. Cell Stem Cell. 28(4):718-731.e6. PubMed
  99. Kumar V, et al. 2022. Cells. 11:. PubMed
  100. Burnett CE, et al. 2022. Immunity. 55:1284. PubMed
  101. Calianese D, et al. 2021. J Immunol. 207:436. PubMed
  102. Ma YV, et al. 2021. MAbs. 13:2003281. PubMed
  103. Vijayakumar B, et al. 2022. Immunity. . PubMed
  104. Pérez-Pérez S, et al. 2021. Front Immunol. 12:798003. PubMed
  105. Chan JM, et al. 2021. Cancer Cell. 39:1479. PubMed
  106. Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed
  107. Toulmin SA, et al. 2021. Nat Commun. 12:3993. PubMed
  108. Stephenson E, et al. 2021. Nat Med. 27:904. PubMed
  109. Fuentes I, et al. 2020. Sci Rep. 10:15064. PubMed
  110. Stuart T, et al. 2019. Cell. 177:1888. PubMed
  111. Gao X, et al. 2017. PLoS One. 10.1371/journal.pone.0189167. PubMed
  112. Dashtsoodol N, et al. 2017. Front Immunol. 10.3389/fimmu.2017.01206. PubMed
  113. Deng H, et al. 2017. Arthritis Res Ther. 10.1186/s13075-017-1339-4. PubMed
  114. Layer JV, et al. 2020. Proc Natl Acad Sci U S A. 27566:117. PubMed
  115. Dogra P, et al. 2020. Cell. 749:180. PubMed
  116. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  117. Linke M, et al. 2017. Nat Immunol. 18:293-302. PubMed
  118. Ciarlo E, et al. 2016. Sci Rep. 6:37944. PubMed
  119. Vir P, et al. 2015. PLoS One. 10: 0144904. PubMed
  120. Poonpanichakul T, et al. 2021. Front Immunol. 12:599805. PubMed
  121. Sen K, et al. 2021. Front Immunol. 12:733539. PubMed
  122. Zheng S, et al. 2022. Blood Cancer Discov. 3:103. PubMed
  123. Quinn TM, et al. 2022. EBioMedicine. 76:103856. PubMed
  124. Vanshylla K, et al. 2022. Cell Host Microbe. 30:69. PubMed
  125. Worwa G, et al. 2022. Commun Biol. 5:1204. PubMed
  126. Zhang W, et al. 2019. Exp Ther Med. 2.490972222. PubMed
  127. Bocharnikov AV, et al. 2019. JCI Insight. 4:e126832. PubMed
  128. Mair F, et al. 2020. Cell Rep. 31:107499. PubMed
  129. Decker D, et al. 2014. Lupus. 123:2663. PubMed
  130. Lisovsky I, et al. 2015. J Virol. 89: 9909 - 9919. PubMed
  131. Busch S, et al. 2016. J Immunol. 197(11):4493-4503. PubMed
  132. Bowen J, et al. 2017. PLoS Pathog. 13(2):e1006164. PubMed
  133. Kreutmair S, et al. 2021. Immunity. . PubMed
  134. Rapiteanu R, et al. 2020. Eur Respir J. :55. PubMed
  135. Harrison TE, et al. 2020. Nature. 309:587. PubMed
  136. Abrecht C, et al. 2022. STAR Protoc. 3:101362. PubMed
  137. Lai ZZ, et al. 2020. Am J Reprod Immunol. 84:e13295. PubMed
  138. Adamik J, et al. 2022. Nat Commun. 13:5184. PubMed
  139. Romine KA, et al. 2021. Blood Cancer Discov. 2:518. PubMed
  140. Vanuytsel K, et al. 2022. Nat Commun. 13:1103. PubMed
  141. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  142. Muir LA, et al. 2022. JCI Insight. 7:. PubMed
  143. Romine KA, et al. 2021. Cancer Discov. . PubMed
  144. Rogers BM, et al. 2021. J Exp Med. 218:. PubMed
  145. Shen Z, et al. 2021. iScience. 24:103014. PubMed
  146. Wu CL, et al. 2021. Nat Commun. 12:362. PubMed
  147. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  148. Qiu XM, et al. 2020. Reproduction. 251:159. PubMed
  149. Gonzalez VD, et al. 2021. Cell Reports. 36(9):109632. PubMed
  150. Obradovic A, et al. 2021. Cell. 184(11):2988-3005.e16. PubMed
  151. Russ K, et al. 2021. Cell Reports. 34(12):108895. PubMed
  152. Marjanovic ND, et al. 2020. Cancer Cell. 38(2):229-246.e13. PubMed
  153. Judge SJ, et al. 2020. J Clin Invest. 130:3051. PubMed
  154. Market M, et al. 2020. Front Immunol. 1.127083333. PubMed
  155. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  156. Zhang S, et al. 2020. Front Immunol. 1.757638889. PubMed
  157. Jitschin R, et al. 2014. Blood. 123:2663. PubMed
  158. Cao Y, et al. 2021. Cell Res. 31:732. PubMed
  159. Wang W, et al. 2021. Clin Transl Med. 11:e253. PubMed
  160. Wang YC, et al. 2021. Nat Commun. 12:3530. PubMed
  161. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  162. Painter MM, et al. 2021. Immunity. 54:2133. PubMed
  163. Syrimi E, et al. 2021. iScience. 24:103215. PubMed
  164. Thijssen R, et al. 2022. Blood. :. PubMed
  165. Good Z, et al. 2022. Nat Med. :. PubMed
  166. Ferrer-Font L, et al. 2021. Curr Protoc. 1:e222. PubMed
  167. Weaver JD, et al. 2022. Oncoimmunology. 11:2141007. PubMed
  168. Souriant S, et al. 2019. Cell Rep. 26:3586. PubMed
  169. Riordon DR, et al. 2017. Methods Mol Biol. 1722:127. PubMed
  170. Edin S, et al. 2013. PLoS One. 18:74982. PubMed
  171. Borg Z, et al. 2014. J Immunol. 192:189. PubMed
  172. Shi J, et al. 2014. Blood. 123:4015. PubMed
  173. Galvani S, et al. 2015. Sci Signal. 8: ra79. PubMed
  174. Boyerinas B, et al. 2015. Cancer Immunol Res. 3: 1148 - 1157. PubMed
  175. Zabransky DJ, et al. 2015. Proc Natl Acad Sci U S A. 112: 6205 -6214. PubMed
  176. Thorek D, et al. 2016. Sci Transl Med. 8: 367ra167. PubMed
  177. Le BV, et al. 2020. Cell Rep. 33:108221. PubMed
  178. Venturutti L, et al. 2020. Cell. 182(2):297-316.e27. PubMed
  179. Lu Q, et al. 2021. Immunity. 54(6):1304-1319.e9. PubMed
  180. Zhang F, et al. 2020. EMBO Mol Med. e12034:12. PubMed
  181. Helmink BA, et al. 2020. Nature. 577:549. PubMed
  182. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  183. Chen Y, et al. 2022. Front Immunol. 13:835690. PubMed
  184. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  185. Jiang Y, et al. 2020. Br J Pharmacol. . PubMed
  186. Yoon J, et al. 2020. Front Cell Dev Biol. 0.520138889. PubMed
  187. Poon E, et al. 2017. J Immunother Cancer. 10.1186/s40425-017-0268-8. PubMed
  188. Opzoomer JW, et al. 2021. Elife. :10. PubMed
  189. Woodruff M, et al. 2020. medRxiv. . PubMed
  190. Nabet BY, et al. 2020. Cell. 183(2):363-376.e13. PubMed
  191. Zobel MJ, et al. 2020. J Immunother Cancer. 8:00. PubMed
  192. Seifert L, et al. 2015. Cell Rep. 13: 1909-1921. PubMed
  193. Punyadee N, et al. 2015. J Virol. 89:1587. PubMed
  194. Chen G, et al. 2021. Signal Transduct Target Ther. 6:289. PubMed
  195. Besnier M, et al. 2021. Antioxidants (Basel). 10:. PubMed
  196. Dugger DT, et al. 2021. Front Immunol. 12:704172. PubMed
  197. Vick SC, et al. 2021. Sci Adv. 7:eabj0274. PubMed
  198. Hu Y, et al. 2021. Am J Hum Genet. 108:874. PubMed
  199. Levi H, et al. 2022. J Exp Med. 219:. PubMed
  200. Jorapur A, et al. 2022. PLoS Pathog. 18:e1010200. PubMed
  201. Trevelin SC, et al. 2022. Front Immunol. 13:838328. PubMed
  202. Ndeupen S, et al. 2021. iScience. 24:103479. PubMed
  203. Zhu S, et al. 2022. J Oncol. 2022:8724933. PubMed
  204. Gadi D, et al. 2022. Leukemia. 36:723. PubMed
  205. Studniberg SI, et al. 2022. Mol Syst Biol. 18:e10824. PubMed
  206. Huang Y, et al. 2022. iScience. 25:105209. PubMed
  207. Quintanal-Villalonga A, et al. 2022. STAR Protoc. 3:101776. PubMed
  208. Liu Y, et al. 2022. Front Oncol. 12:1037934. PubMed
  209. Zhu Y, et al. 2019. Cell Stem Cell. 25:542. PubMed
  210. Giurisato E, et al. 2014. Mol Biol Cell. 25:1769. PubMed
  211. Lundholm M, et al. 2015. Sci Rep. 5: 15651. PubMed
  212. Revelo X, et al. 2016. Cell Rep. 16: 717-730. PubMed
  213. Thomas K, et al. 2016. J Leukoc Biol. 100: 177 - 184. PubMed
  214. Burns JC, et al. 2020. eLife. 9:00. PubMed
  215. Herati RS, et al. 2021. Cell Reports Medicine. 2(5):100262. PubMed
  216. Ziegler CGK, et al. 2021. Cell. 184(18):4713-4733.e22. PubMed
  217. An Y, et al. 2021. Sci Rep. 6392:11. PubMed
  218. Reustle A, et al. 2022. Clin Transl Med. 12:e883. PubMed
  219. Bahcecioglu G, et al. 2021. Adv Sci (Weinh). 8:e2100128. PubMed
  220. Li G, et al. 2021. Curr Protoc. 1:e50. PubMed
  221. Anadon CM, et al. 2022. STAR Protoc. 3:101649. PubMed
  222. Nadeu F, et al. 2022. Nat Med. 28:1662. PubMed
  223. Hirschberger S, et al. 2022. Front Med (Lausanne). 9:923502. PubMed
  224. Pathania AS, et al. 2022. Mol Ther Oncolytics. 25:308. PubMed
  225. Wang J, et al. 2022. iScience. 25:103971. PubMed
  226. Wu Y, et al. 2022. J Cancer Res Clin Oncol. . PubMed
  227. Woolley CR, et al. 2022. Immunohorizons. 6:47. PubMed
  228. Wendisch D, et al. 2021. Cell. 184:6243. PubMed
  229. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  230. Poon MML, et al. 2021. Cell Rep. 37:110071. PubMed
  231. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  232. Wegner J, et al. 2021. Sci Rep. 11:14983. PubMed
  233. Sun L, et al. 2021. Sci Rep. 11:12477. PubMed
  234. Cruz J, et al. 2011. J Immunol. 186:2282. PubMed
  235. Li H, et al. 2021. Adv Sci (Weinh). 2001596:8. PubMed
  236. OConnor RA, et al. 2021. OncoImmunology. 10(1):1940675. PubMed
  237. Cheng Y, et al. 2021. Immunity. 54(8):1825-1840.e7. PubMed
  238. Glassman CR, et al. 2021. Cell. 184(4):983-999.e24. PubMed
  239. Zeng J, et al. 2020. Nat Med. 26:535. PubMed
  240. Wang C, et al. 2015. Clin Immunol. 159: 47-57. PubMed
  241. Luo L, et al. 2011. Exp Mol Pathol. 91:596. PubMed
  242. Li YR, et al. 2021. Cell Rep Med. 2:100449. PubMed
  243. Mudd PA, et al. 2022. Cell. 185:603. PubMed
  244. Kusi M, et al. 2022. Cell Rep. 38:110220. PubMed
  245. Dahal S, et al. 2022. Retrovirology. 19:18. PubMed
  246. Cortés-López M, et al. 2022. Nat Commun. 13:5570. PubMed
  247. Qin XH, et al. 2019. Langmuir. 35:1882. PubMed
  248. Song M, et al. 2018. Nature. 562:423. PubMed
  249. Good Z, et al. 2019. Nat Biotechnol. 37:259. PubMed
  250. Xue J, et al. 2020. Arthritis Res Ther. 1.070138889. PubMed
  251. Tsuboki J, et al. 2016. Sci Rep. 6:29588. PubMed
  252. Gao M, et al. 2016. Sci Rep. 6:29955. PubMed
  253. Stephanie Elizabeth, Johanna Zandee 2017. Immunol Cell Biol. 10.1038/icb.2017.3. PubMed
  254. Morales Pantoja IE, et al. 2020. PLoS One. 15:e0233980. PubMed
  255. Huetter J, et al. 2020. Cancer Immunol Res. 0.954861111. PubMed
  256. Still C 2nd, et al. 2021. Cell Reports Medicine. 2(7):100343. PubMed
  257. Feng W, et al. 2020. J Vis Exp. . PubMed
  258. Hannon E, et al. 2021. PLoS Genet. e1009443:17. PubMed
  259. Huang D, et al. 2022. Cell Discov. 8:121. PubMed
  260. Shemesh A, et al. 2022. J Exp Med. 219:. PubMed
  261. Michelozzi IM, et al. 2022. STAR Protoc. 3:101174. PubMed
  262. Lo YC, et al. 2022. Nat Commun. 13:934. PubMed
  263. Thakkar D, et al. 2022. J Immunother Cancer. 10:. PubMed
  264. Erickson JR, et al. 2022. Proc Natl Acad Sci U S A. 119:. PubMed
  265. Wang X, et al. 2022. J Immunol. 208:396. PubMed
  266. Fang F, et al. 2021. Cell Rep. 37:109981. PubMed
  267. Paul S, et al. 2021. Sci Transl Med. 13:. PubMed
  268. Combes AJ, et al. 2021. Nature. 591:124. PubMed
  269. Ellyard JI, et al. 2019. Front Immunol. 1.898611111. PubMed
  270. Fan C, et al. 2019. Mol Med Rep. 3.002083333. PubMed
  271. Franco LM, et al. 2019. J Exp Med. 216:384. PubMed
  272. Oetjen KA, et al. 2018. JCI Insight. 3:e124928. PubMed
  273. Jiang X, et al. 2018. Cell Mol Immunol. 1.338194444. PubMed
  274. Gov L,et al. 2017. J Immunol. 10.4049/jimmunol.1700245. PubMed
  275. Metcalf T, et al. 2017. J Immunol. 10.4049/jimmunol.1700148. PubMed
  276. Larson-Casey JL, et al. 2020. PLoS One. 15:e0241323. PubMed
  277. Carmona-Rivera C, et al. 2020. JCI Insight. 5:00. PubMed
  278. Surendran N, et al. 2016. Innate Immunity. 22: 63 - 71. PubMed
  279. Lines J, et al. 2014. Cancer Res. 74:1924. PubMed
  280. Alves V, et al. 2013. Infect Immun . 81:4399. PubMed
  281. Hoffmann J, et al. 2021. Nat Commun. 12:3964. PubMed
  282. Zhang X, et al. 2021. Nat Commun. 12:4536. PubMed
  283. Hirschberger S, et al. 2021. EMBO Mol Med. 13:e14323. PubMed
  284. Liao M, et al. 2021. Aging (Albany NY). 13:22412. PubMed
  285. Gutierrez C, et al. 2021. Nat Cancer. 2:758. PubMed
  286. Georg P, et al. 2022. Cell. 185:493. PubMed
  287. Céspedes PF, et al. 2022. Nat Commun. 13:3460. PubMed
  288. Zhang F, et al. 2021. Genome Med. 13:64. PubMed
  289. Luque-Martin R, et al. 2021. J Immunol. 207:555. PubMed
  290. Li F, et al. 2022. Nat Commun. 13:4334. PubMed
  291. Rydyznski Moderbacher C, et al. 2022. J Clin Invest. :. PubMed
  292. Hwang B, et al. 2021. Nat Methods. 18:903. PubMed
  293. Montel-Hagen A, et al. 2022. Curr Protoc. 2:e403. PubMed
  294. López-Sanz C, et al. 2022. STAR Protoc. 3:101755. PubMed
  295. Guo JJ, et al. 2017. Exp Ther Med. 3.842361111. PubMed
  296. Zhao Y, et al. 2020. Immunity. 51(6):1059-1073.e9.. PubMed
  297. Nobre LV, et al. 2020. eLife. 8:e49894.. PubMed
  298. Szerlip N, et al. 2012. Proc Natl Acad Sci U S A. 109:3041. PubMed
  299. Bromley S, et al. 2013. J Immunol. 190:970. PubMed
  300. Lieber S, et al. 2014. Mol Pharmacol. 87:162. PubMed
  301. Page K, et al. 2015. J Pharmacol Exp Ther. 355: 199 - 205. PubMed
  302. Wanke-Jellinek L, et al. 2016. J Immunol. 196: 767 - 777. PubMed
  303. Schneeberger V, et al. 2016. PLoS One. 11: 0160587. PubMed
  304. Maini A, et al. 2016. PLoS One. 11:e0165502. PubMed
  305. Burel J, et al. 2016. PLoS Negl Trop Dis. 10:e0005031. PubMed
  306. Kirabo A, et al. 2017. J Mol Cell Cardiol. 10.1016/j.yjmcc.2017.03.001. PubMed
  307. Judge SJ, et al. 2020. J Immunother Cancer. 8:00. PubMed
  308. Greenlee JD, et al. 2021. eLife. 0.416666666666667. PubMed
  309. Herland A, et al. 2020. Nat Biomed Eng. 421:4. PubMed
  310. Hepprich M, et al. 2020. Cell Metab. 699:31. PubMed
  311. Demaree B, et al. 2021. Nat Commun. 1583:12. PubMed
  312. Strazza M, et al. 2022. Mol Ther Methods Clin Dev. 27:380. PubMed
  313. Konkimalla A, et al. 2022. iScience. 25:105114. PubMed
  314. Tang JS, et al. 2022. Front Immunol. 13:946713. PubMed
  315. Liu Y, et al. 2022. Clin Transl Med. 12:e654. PubMed
  316. Ruan LY, et al. 2022. Biomolecules. 12:. PubMed
  317. Lederer K, et al. 2022. Cell. . PubMed
  318. Wang YM, et al. 2022. Oncoimmunology. 11:2034257. PubMed
  319. Jiang J, et al. 2021. Front Immunol. 12:785549. PubMed
  320. Yang Y, et al. 2021. Emerg Microbes Infect. 10:905. PubMed
  321. Wierzbinska JA, et al. 2020. Genome Med. 12:29. PubMed
  322. Bricio–Moreno L, et al. 2018. Nat Commun. 2.204861111. PubMed
  323. Arrigucci R, et al. 2017. Nat Protoc. 1.364583333. PubMed
  324. Shuwa HA, et al. 2021. Med. 2(6):720-735.e4. PubMed
  325. Landgraf KE, et al. 2020. Commun Biol. 0.330555556. PubMed
  326. Nahid M, et al. 2016. J Leukoc Biol. 100: 339 - 349. PubMed
  327. Eichten A, et al. 2016. Cancer Res . 76: 2327-2339. PubMed
  328. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  329. Rovira-Clavé X, et al. 2021. Nat Commun. 12:4628. PubMed
  330. Wurm M, et al. 2021. Mol Cancer Ther. 20:2250. PubMed
  331. Pauken CM, et al. 2021. Cancers (Basel). 13:. PubMed
  332. Genge PC, et al. 2021. STAR Protoc. 2:100900. PubMed
  333. Winkler C, et al. 2021. JCI Insight. 6:. PubMed
  334. Adamo S, et al. 2022. Nature. 602:148. PubMed
  335. Krijgsman D, et al. 2022. STAR Protoc. 3:101034. PubMed
  336. Hallisey M, et al. 2022. STAR Protoc. 3:101163. PubMed
  337. Konishi S, et al. 2022. STAR Protoc. 3:101447. PubMed
  338. Galván-Peña S, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  339. Wilson TL, et al. 2022. Cancer Discov. 12:2098. PubMed
  340. Claireaux MAF, et al. 2022. Nat Commun. 13:4539. PubMed
  341. Allard-Chamard H, et al. 2021. J Immunol. 206:524. PubMed
  342. Maas RR, et al. 2021. Nat Protoc. 16:4692. PubMed
  343. Mujal AM, et al. 2022. Cancer Immunol Res. 10:403. PubMed
  344. Delgado-Gonzalez A, et al. 2022. STAR Protoc. 3:101425. PubMed
  345. Chou DB, et al. 2022. Nat Commun. 13:6021. PubMed
  346. Sade–Feldman M, et al. 2018. Cell. 175:998. PubMed
  347. Kubala MH, et al. 2018. Cell Rep. 25:2177. PubMed
  348. Wu X, et al. 2020. Front Immunol. 1.922222222. PubMed
  349. Bhardwaj N, et al. 2014. J Virol. 88:11108. PubMed
  350. Olagnier D, et al. 2014. PLoS Pathog. 10:1004566. PubMed
  351. Wilkinson-Ryan I, et al. 2015. PLoS One. 10:125851. PubMed
  352. Ali A, et al. 2015. PLoS One. 10: 0131645. PubMed
  353. Kanzaki H, et al. 2016. Sci Rep. 6:32259. PubMed
  354. Goehring K, et al. 2016. J Nutr. 146(12):2559-2566. PubMed
  355. Festag J, et al. 2020. Mol Ther Nucleic Acids. 1.330555556. PubMed
  356. Maehara T, et al. 2020. J Clin Invest. 130:2451. PubMed
  357. Mathewson ND, et al. 2021. Cell. 184(5):1281-1298.e26. PubMed
  358. Szodoray P, et al. 2021. Cell Reports. 36(6):109525. PubMed
  359. Jin HS, et al. 2020. Cancer Immunol Res. 8:912. PubMed
  360. Olafsdottir TA, et al. 2022. Commun Biol. 5:914. PubMed
  361. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  362. Alhussan A, et al. 2022. Cancers (Basel). 14:. PubMed
  363. Lee PC, et al. 2022. J Clin Invest. 132:. PubMed
  364. Rouhani SJ, et al. 2022. J Immunother Cancer. 10:. PubMed
  365. Chan M, et al. 2021. Mol Syst Biol. 17:e10426. PubMed
  366. Rodríguez-Lorenzo S, et al. 2022. Elife. 11:. PubMed
  367. Vechetti IJ, et al. 2021. FASEB J. 35:e21644. PubMed
  368. Manríquez V, et al. 2021. Nat Commun. 12:4547. PubMed
  369. Tomita T, et al. 2021. Nat Commun. 12:3655. PubMed
  370. Sontheimer-Phelps A, et al. 2019. Cell Mol Gastroenterol Hepatol. 9:507. PubMed
  371. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  372. Cai Q, et al. 2019. Oncol Lett. 2.967361111. PubMed
  373. Yang ZZ, et al. 2019. Cell Rep. 26:2178. PubMed
  374. Salahudeen AA, et al. 2020. bioRxiv. . PubMed
  375. Qi J, et al. 2021. Cell Reports Medicine. 2(8):100353. PubMed
  376. Hara T, et al. 2021. Cancer Cell. 39(6):779-792.e11. PubMed
  377. Clayton KL, et al. 2021. Cell Host Microbe. 29(3):435-447.e9. PubMed
  378. Nielsen S, et al. 2016. Nat Cell Biol. 18: 549-560. PubMed
  379. Jarantow S, et al. 2015. J Biol Chem. 290: 24689 - 24704. PubMed
  380. Anderson M, et al. 2014. Otolaryngology Head Neck Surg. 150:880. PubMed
  381. Shaw BC, et al. 2021. CRISPR J. 4:699. PubMed
  382. Chen C, et al. 2022. iScience. 25:103645. PubMed
  383. Lu J, et al. 2022. STAR Protoc. 3:101559. PubMed
  384. Ainsworth RI, et al. 2022. Nat Commun. 13:6221. PubMed
  385. Lynskey N, et al. 2017. PLoS Pathog.. 10.1371/journal.ppat.1006493. PubMed
  386. Eitas T, et al. 2017. PLoS One. 10.1371/journal.pone.0184164. PubMed
  387. Verma SK, et al. 2018. J Biol Chem. 293:254. PubMed
  388. Pleguezuelos O, et al. 2015. Clin Vaccine Immunol. 22: 828 - 835. PubMed
  389. Alasoo K, et al. 2015. Sci Rep. 5: 12524. PubMed
  390. Burel J, et al. 2016. PLoS Pathog. 12: 1005839. PubMed
  391. MacBride M, et al. 2017. Mammalian Genome. 10.1007/s00335-017-9680-0. PubMed
  392. Chou DB, et al. 2020. Nat Biomed Eng. 0.440277778. PubMed
  393. Nistler R, et al. 2020. Immunohorizons. 0.397222222. PubMed
  394. Pettmann J, et al. 2021. eLife. 10:00. PubMed
  395. Luoma AM, et al. 2020. Cell. 182(3):655-671.e22. PubMed
  396. Perugino CA, et al. 2021. J Allergy Clin Immunol. 368:147. PubMed
  397. Jeong HO, et al. 2022. iScience. 25:105358. PubMed
  398. Murphy DM, et al. 2022. J Clin Invest. Online ahead of print. PubMed
  399. Faissner S, et al. 2022. Front Immunol. 13:980526. PubMed
  400. Zha Y, et al. 2022. Front Immunol. 13:877314. PubMed
  401. Wang H, et al. 2022. J Cancer. 13:2126. PubMed
  402. Medeiros-Furquim T, et al. 2022. Front Immunol. 13:678817. PubMed
  403. Kaya-Tilki E, et al. 2021. PLoS One. 16:e0260633. PubMed
  404. Kämpe A, et al. 2021. PLoS One. 16:e0257442. PubMed
  405. Pinto SM, et al. 2021. Front Immunol. 12:679458. PubMed
  406. Chiou SH, et al. 2021. Immunity. 54:586. PubMed
  407. Wang EY, et al. 2021. Nature. 595:283. PubMed
  408. Binnewies M, et al. 2019. Cell. 177:556. PubMed
  409. Nightingale K, et al. 2018. Cell Host Microbe. 24:447. PubMed
  410. Itoh H, et al. 2017. J Vet Med. 10.1155/2017/5701016. PubMed
  411. Kamada R, et al. 2017. The Journal of Biochemistry. 10.1093/jb/mvx032. PubMed
  412. Yao W, et al. 2017. Molecular Immunology. 10.1016/j.molimm.2017.04.017. PubMed
  413. Mpakou V, et al. 2021. Exp Ther Med. 1.010416667. PubMed
  414. Scharenberg SG, et al. 2020. Nat Commun. 2.76875. PubMed
  415. Sainson RCA, et al. 2020. Cancer Immunol Res. 1.422222222. PubMed
  416. Salahudeen AA, et al. 2020. Nature. 588:670. PubMed
  417. Okamura Y, et al. 2017. Allergol Int. 10.1016/j.alit.2017.03.002. PubMed
  418. An L, et al. 2016. Sci Rep. 6: 33346. PubMed
  419. Wolf J, et al. 2016. J Biol Chem. 291: 16186 - 16196. PubMed
  420. Schneck H, et al. 2015. PLoS One. 10: 0144535. PubMed
RRID
AB_2818986 (BioLegend Cat. No. 422302)

Antigen Details

Molecular Family
Fc Receptors
Gene ID
NA

Related FAQs

Is our human Trustain FcX™ (cat# 422302) compatible with anti human CD16, CD32 and CD64 clones 3G8, FUN-2 and 10.1 respectively?

Yes

What is the concentration of Human TruStain FcX™ (Fc receptor blocking solution, Cat#422301)?
This information is proprietary.
Go To Top Version: 4    Revision Date: 07.14.2016

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account